[{"id":"30859415-1eaf-4635-915e-82405f408c4f","acronym":"","url":"https://clinicaltrials.gov/study/NCT00600275","created_at":"2021-01-18T02:13:23.567Z","updated_at":"2024-07-02T16:36:37.185Z","phase":"Phase 1/2","brief_title":"A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer","source_id_and_acronym":"NCT00600275","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" ER • PGR","pipe":" | ","alterations":" HER-2 positive • HER-2 expression","tags":["ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BGT226"],"overall_status":"Completed","enrollment":" Enrollment 57","initiation":"Initiation: 12/01/2007","start_date":" 12/01/2007","primary_txt":" Primary completion: 03/01/2010","primary_completion_date":" 03/01/2010","study_txt":"","study_completion_date":"","last_update_posted":"2020-12-17"}]